Elyse Stock M.D.
Net Worth

Last updated:

What is Elyse Stock M.D. net worth?

The estimated net worth of Dr. Elyse Stock M.D. is at least $10,131,068 as of 10 Jan 2022. He owns shares worth $140,277 as insider, has earned $5,630,051 from insider trading and has received compensation worth at least $4,360,740 in Biohaven Pharmaceutical Holding Company Ltd..

What is the salary of Elyse Stock M.D.?

Dr. Elyse Stock M.D. salary is $726,790 per year as Chief Medical Officer in Biohaven Pharmaceutical Holding Company Ltd..

How old is Elyse Stock M.D.?

Dr. Elyse Stock M.D. is 67 years old, born in 1958.

What stocks does Elyse Stock M.D. currently own?

As insider, Dr. Elyse Stock M.D. owns shares in one company:

Company Title Shares Price per share Total value
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Chief Medical Officer 9,056 $15.49 $140,277

What does Biohaven Pharmaceutical Holding Company Ltd. do?

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

BHVN logo
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
$15.49

Elyse Stock M.D. insider trading

Biohaven Pharmaceutical Holding Company Ltd.

Dr. Elyse Stock M.D. has made 5 insider trades between 2019-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 36,966 units of BHVN stock on 12 Jun 2020. As of 10 Jan 2022 he still owns at least 9,056 units of BHVN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Share Unit Award 937 N/A N/A
Option
Common Shares 937 N/A N/A
Option
Restricted Share Unit Award 9,250 N/A N/A
Option
Employee Stock Option (right to buy) 26,000 $128.87 $3,350,620
Option
Common Shares 4,250 N/A N/A
Option
Common Shares 5,000 N/A N/A
Option
Common Shares 21,919 $15.81 $346,430
Sale
Common Shares 21,919 $105.8 $2,319,030
Option
Employee Stock Option (Right to Buy) 28,858 $15.81 $456,101
Option
Common Shares 6,939 $15.81 $109,671
Sale
Common Shares 6,939 $105.02 $728,762
Option
Common Shares 3,375 N/A N/A
Option
Restricted Share Unit Award 3,375 N/A N/A
Option
Restricted Share Unit Award 5,000 N/A N/A
Option
Common Shares 5,000 N/A N/A
Option
Restricted Share Unit Award 5,000 N/A N/A
Option
Common Shares 5,000 N/A N/A
Option
Restricted Share Unit Award 3,375 N/A N/A
Option
Common Shares 3,375 N/A N/A
Option
Common Shares 36,966 $26.61 $983,480
Sale
Common Shares 36,966 $64.44 $2,382,089
Option
Employee Stock Option (Right to Buy) 36,966 $26.61 $983,480
Option
Restricted Share Unit Award 4,687 $27.96 $131,025
Option
Common Shares 937 $55.91 $52,388
Option
Restricted Share Unit Award 937 $55.91 $52,388
Option
Restricted Share Unit Award 3,375 $52.13 $175,939
Option
Common Shares 3,375 $52.13 $175,939
Sale
Common Shares 17,700 $10.82 $191,514
Option
Employee Stock Option (Right to Buy) 17,700 $10.82 $191,514
Option
Common Shares 17,700 $10.82 $191,514
Option
Employee Stock Option (Right to Buy) 800 $10.82 $8,656
Sale
Common Shares 800 $10.82 $8,656
Option
Common Shares 800 $10.82 $8,656

Biohaven Pharmaceutical Holding Company Ltd. key executives

Biohaven Pharmaceutical Holding Company Ltd. executives and other stock owners filed with the SEC:

  • Dr. Elyse Stock M.D. (67) Chief Medical Officer
  • Dr. Vladimir Coric M.D. (54) Chairman, Chief Executive Officer & Pres
  • Mr. William Jones M.B.A. (61) Chief Commercial Officer of Migraine & Common Diseases
  • Ms. Kimberly Gentile (59) Senior Vice President of Clinical Operations